Jump to content

DYM: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
No edit summary
moving link to cite
 
(One intermediate revision by one other user not shown)
Line 4: Line 4:
'''Dymeclin''' is a [[protein]] that in humans is encoded by the ''DYM'' [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: DYM dymeclin| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=54808| accessdate = }}</ref>
'''Dymeclin''' is a [[protein]] that in humans is encoded by the ''DYM'' [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: DYM dymeclin| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=54808| accessdate = }}</ref>


This gene encodes a protein which is necessary for normal skeletal development and [[Brain|brain function]] and has been first described and named in 2003 (https://pubmed.ncbi.nlm.nih.gov/12554689/). Mutations in this gene are associated with two types of recessive [[osteochondrodysplasias]], Dyggve-Melchior-Clausen (DMC) [[syndrome]], which involves both skeletal defects and postnatal microcephaly with intellectual deficiency, and Smith-McCort (SMC) dysplasia, which involves skeletal defects only.<ref name="entrez"/>
This gene encodes a protein which is necessary for normal skeletal development and [[Brain|brain function]] and has been first described and named in 2003.<ref name="El Ghouzzi 2003 pp. 357–364">{{cite journal | last=El Ghouzzi | first=V. | title=Mutations in a novel gene Dymeclin (FLJ20071) are responsible for Dyggve-Melchior-Clausen syndrome | journal=Human Molecular Genetics | publisher=Oxford University Press (OUP) | volume=12 | issue=3 | date=2003-02-01 | issn=1460-2083 | doi=10.1093/hmg/ddg029 | pages=357–364 |pmid=12554689}}</ref> Mutations in this gene are associated with two types of recessive [[osteochondrodysplasias]], Dyggve-Melchior-Clausen (DMC) [[syndrome]], which involves both skeletal defects and postnatal microcephaly with intellectual deficiency, and Smith-McCort (SMC) dysplasia, which involves skeletal defects only.<ref name="entrez"/>


==References==
==References==
Line 20: Line 20:
*{{cite journal | vauthors=Ota T, Suzuki Y, Nishikawa T |title=Complete sequencing and characterization of 21,243 full-length human cDNAs |journal=Nat. Genet. |volume=36 |issue= 1 |pages= 40–5 |year= 2004 |pmid= 14702039 |doi= 10.1038/ng1285 |display-authors=etal|doi-access=free }}
*{{cite journal | vauthors=Ota T, Suzuki Y, Nishikawa T |title=Complete sequencing and characterization of 21,243 full-length human cDNAs |journal=Nat. Genet. |volume=36 |issue= 1 |pages= 40–5 |year= 2004 |pmid= 14702039 |doi= 10.1038/ng1285 |display-authors=etal|doi-access=free }}
*{{cite journal | vauthors=Gerhard DS, Wagner L, Feingold EA |title=The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC) |journal=Genome Res. |volume=14 |issue= 10B |pages= 2121–7 |year= 2004 |pmid= 15489334 |doi= 10.1101/gr.2596504 | pmc=528928 |display-authors=etal}}
*{{cite journal | vauthors=Gerhard DS, Wagner L, Feingold EA |title=The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC) |journal=Genome Res. |volume=14 |issue= 10B |pages= 2121–7 |year= 2004 |pmid= 15489334 |doi= 10.1101/gr.2596504 | pmc=528928 |display-authors=etal}}
*{{cite journal | vauthors=Clark TA, Schweitzer AC, Chen TX |title=Discovery of tissue-specific exons using comprehensive human exon microarrays |journal=Genome Biol. |volume=8 |issue= 4 |pages= R64 |year= 2007 |pmid= 17456239 |doi= 10.1186/gb-2007-8-4-r64 | pmc=1896007 |display-authors=etal}}
*{{cite journal | vauthors=Clark TA, Schweitzer AC, Chen TX |title=Discovery of tissue-specific exons using comprehensive human exon microarrays |journal=Genome Biol. |volume=8 |issue= 4 |pages= R64 |year= 2007 |pmid= 17456239 |doi= 10.1186/gb-2007-8-4-r64 | pmc=1896007 |display-authors=etal |doi-access=free }}
{{refend}}
{{refend}}



Latest revision as of 17:40, 23 January 2024

DYM
Identifiers
AliasesDYM, DMC, SMC, dymeclin
External IDsOMIM: 607461; MGI: 1918480; HomoloGene: 69237; GeneCards: DYM; OMA:DYM - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_027727

RefSeq (protein)

NP_082003

Location (UCSC)Chr 18: 49.04 – 49.46 MbChr 18: 75.15 – 75.42 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Dymeclin is a protein that in humans is encoded by the DYM gene.[5]

This gene encodes a protein which is necessary for normal skeletal development and brain function and has been first described and named in 2003.[6] Mutations in this gene are associated with two types of recessive osteochondrodysplasias, Dyggve-Melchior-Clausen (DMC) syndrome, which involves both skeletal defects and postnatal microcephaly with intellectual deficiency, and Smith-McCort (SMC) dysplasia, which involves skeletal defects only.[5]

References

[edit]
  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000141627Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000035765Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ a b "Entrez Gene: DYM dymeclin".
  6. ^ El Ghouzzi, V. (2003-02-01). "Mutations in a novel gene Dymeclin (FLJ20071) are responsible for Dyggve-Melchior-Clausen syndrome". Human Molecular Genetics. 12 (3). Oxford University Press (OUP): 357–364. doi:10.1093/hmg/ddg029. ISSN 1460-2083. PMID 12554689.

Further reading

[edit]